nach oben

Archivum Immunologiae et Therapiae Experimentalis

Erschienen in:

01.12.2022 | Review

Special Issue: Novel Diagnostic and Therapeutic Approach Options in Lupus Nephritis

Transcriptome Studies in Lupus Nephritis

verfasst von: Marta E. Alarcón-Riquelme

Erschienen in: Archivum Immunologiae et Therapiae Experimentalis | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

The present review is aimed at describing the main works that have used gene expression to analyze tissue kidney samples of lupus nephritis patients. Most studies used the gene expression arrays, which enormously advanced our knowledge on the possible mechanisms behind lupus nephritis. However, using bulk gene expression platforms, either as arrays, or as sequencing of RNA is not enough to go into detail of the cells and their molecular patterns and single cell mechanisms of disease. More recently, the first single cell RNA Sequencing study was published and this will also be discussed in the context of lupus nephritis. Single cell RNA sequencing allows to retrieve the genes expressed in each cell in the tissue of interest or in blood. In this context, the results of such studies give us a first glimpse of how a lupus nephritis kidney looks like, but much is still to be done to understand the changes that occur with treatment or with the different pathological subtypes of lupus nephritis and their cellular content.

Vorheriger Artikel Hydroxychloroquine Therapy and Serum Immunoglobulin Levels in Women with IgG Subclass Deficiency and Systemic Lupus Erythematosus, Sjögren Syndrome, and Rheumatoid Arthritis: A Retrospective Study

Nächster Artikel Sex Differences in Innate Immune Response of Peripheral Blood Leukocytes of Alzheimer’s Disease Patients

Abdelati AA, Eshak NY, Donia HM et al (2021) Urinary cellular profile as a biomarker for lupus nephritis. J Clin Rheumatol 27:e469–e476CrossRefPubMed

Arazi A, Rao DA, Berthier CC et al (2019) The immune cell landscape in kidneys of patients with lupus nephritis. Nat Immunol 20:902–914CrossRefPubMedPubMedCentral

Banchereau R, Hong S, Cantarel B et al (2016) Personalized immunomonitoring uncovers molecular networks that stratify lupus patients. Cell 165:1548–1550CrossRefPubMed

Blazer A, Dey ID, Nwaukoni J et al (2021) Apolipoprotein L1 risk genotypes in Ghanaian patients with systemic lupus erythematosus: a prospective cohort study. Lupus Sci Med 8:e000460CrossRefPubMedPubMedCentral

Bolin K, Sandling JK, Zickert A et al (2013) Association of STAT4 polymorphism with severe renal insufficiency in lupus nephritis. PLoS ONE 8:e84450CrossRefPubMedPubMedCentral

Chaussabel D, Quinn C, Shen J et al (2008) A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity 29:150–164CrossRefPubMedPubMedCentral

Der E, Suryawanshi H, Morozov P et al (2019) Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways. Nat Immunol 20:915–927CrossRefPubMedPubMedCentral

Dey-Rao R, Smith JR, Chow S et al (2014) Differential gene expression analysis in CCLE lesions provides new insights regarding the genetics basis of skin vs. systemic disease. Genomics 104:144–155CrossRefPubMed

Freedman BI, Langefeld CD, Andringa KK et al (2014) End-stage renal disease in African Americans with lupus nephritis is associated with APOL1. Arthritis Rheum 66:390–396CrossRef

Hagberg N, Ronnblom L (2019) Interferon-alpha enhances the IL-12-induced STAT4 activation selectively in carriers of the STAT4 SLE risk allele rs7574865[T]. Ann Rheum Dis 78:429–431CrossRefPubMed

Jourde-Chiche N, Whalen E, Gondouin B et al (2017) Modular transcriptional repertoire analyses identify a blood neutrophil signature as a candidate biomarker for lupus nephritis. Rheumatology 56:477–487PubMed

Ju W, Nair V, Smith S et al (2015) Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker. Sci Transl Med 7:316ra193CrossRefPubMedPubMedCentral

Khan SQ, Khan I, Gupta V (2018) CD11b activity modulates pathogenesis of lupus nephritis. Front Med 5:52CrossRef

Kim-Howard X, Maiti AK, Anaya JM et al (2010) ITGAM coding variant (rs1143679) influences the risk of renal disease, discoid rash and immunological manifestations in patients with systemic lupus erythematosus with European ancestry. Ann Rheum Dis 69:1329–1332CrossRefPubMed

Kitagawa A, Tsuboi N, Yokoe Y et al (2019) Urinary levels of the leukocyte surface molecule CD11b associate with glomerular inflammation in lupus nephritis. Kidney Int 95:680–692CrossRefPubMed

Lewis MJ, Barnes MR, Blighe K et al (2019) Molecular portraits of early rheumatoid arthritis identify clinical and treatment response phenotypes. Cell Rep 28:2455-2470.e2455CrossRefPubMedPubMedCentral

Lin CP, Adrianto I, Lessard CJ et al (2012) Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis. Genes Immun 13:232–238CrossRefPubMed

Liu K, Li QZ, Delgado-Vega AM et al (2009) Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans. J Clin Invest 119:911–923CrossRefPubMedPubMedCentral

Marciano DK (2019) Mesangial cells: the tuft guys of glomerular development. J Am Soc Nephrol 30:1551–1553CrossRefPubMedPubMedCentral

Mejia-Vilet JM, Parikh SV, Song H et al (2019) Immune gene expression in kidney biopsies of lupus nephritis patients at diagnosis and at renal flare. Nephrol Dial Transplant 34:1197–1206CrossRefPubMed

Morell M, Perez-Cozar F, Maranon C (2021) Immune-related urine biomarkers for the diagnosis of lupus nephritis. Int J Mol Sci 22:7143CrossRefPubMedPubMedCentral

Nakou M, Knowlton N, Frank MB et al (2008) Gene expression in systemic lupus erythematosus: bone marrow analysis differentiates active from inactive disease and reveals apoptosis and granulopoiesis signatures. Arthritis Rheum 58:3541–3549CrossRefPubMedPubMedCentral

Nath SK, Han S, Kim-Howard X et al (2008) A nonsynonymous functional variant in integrin-alpha(M) (encoded by ITGAM) is associated with systemic lupus erythematosus. Nat Genet 40:152–154CrossRefPubMed

Nowling TK (2022) Mesangial cells in lupus nephritis. Curr Rheumatol Rep 23:83CrossRefPubMed

Nzeusseu Toukap A, Galant C, Theate I et al (2007) Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus. Arthritis Rheum 56:1579–1588CrossRefPubMed

Pamfil C, Makowska Z, Groof De et al (2018) Intrarenal activation of adaptive immune effectors is associated with tubular damage and impaired renal function in lupus nephritis. Ann Rheum Dis 77:1782–1789CrossRefPubMed

Peterson KS, Huang JF, Zhu J et al (2004) Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli. J Clin Invest 113:1722–1733CrossRefPubMedPubMedCentral

Reid S, Hagberg N, Sandling JK et al (2021) Interaction between the STAT4 rs11889341 (T) risk allele and smoking confers increased risk of myocardial infarction and nephritis in patients with systemic lupus erythematosus. Ann Rheum Dis 80:1183–1189CrossRefPubMed

Richman IB, Taylor KE, Chung SA et al (2012) European genetic ancestry is associated with a decreased risk of lupus nephritis. Arthritis Rheum 64:3374–3382CrossRefPubMed

Rubtsova K, Rubtsov AV, Cancro MP et al (2015) Age-associated B cells: a T-bet-dependent effector with roles in protective and pathogenic immunity. J Immunol 195:1933–1937CrossRefPubMed

Sanchez E, Nadig A, Richardson BC et al (2011) Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus. Ann Rheum Dis 70:1752–1757CrossRefPubMed

Sanchez E, Rasmussen A, Riba L et al (2012) Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian-European populations. Arthritis Rheum 64:3687–3694CrossRefPubMedPubMedCentral

Taylor KE, Remmers EF, Lee AT et al (2008) Specificity of the STAT4 genetic association for severe disease manifestations of systemic lupus erythematosus. PLoS Genet 4:e1000084CrossRefPubMedPubMedCentral

Toro-Dominguez D, Martorell-Marugan J, Goldman D et al (2018) Stratification of systemic lupus erythematosus patients into three groups of disease activity progression according to longitudinal gene expression. Arthritis Rheumatol 70:2025–2035CrossRefPubMedPubMedCentral

Weening JJ, D’Agati VD, Schwartz MM et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 65:521–530CrossRefPubMed

Wei K, Korsunsky I, Marshall JL et al (2020) Notch signalling drives synovial fibroblast identity and arthritis pathology. Nature 582:259–264CrossRefPubMedPubMedCentral

Wither JE, Prokopec SD, Noamani B et al (2018) Identification of a neutrophil-related gene expression signature that is enriched in adult systemic lupus erythematosus patients with active nephritis: Clinical/pathologic associations and etiologic mechanisms. PLoS ONE 13:e0196117CrossRefPubMedPubMedCentral

Yang W, Zhao M, Hirankarn N et al (2009) ITGAM is associated with disease susceptibility and renal nephritis of systemic lupus erythematosus in Hong Kong Chinese and Thai. Hum Mol Genet 18:2063–2070CrossRefPubMedPubMedCentral

Zumaquero E, Stone SL, Scharer CD et al (2019) IFNgamma induces epigenetic programming of human T-bet(hi) B cells and promotes TLR7/8 and IL-21 induced differentiation. Elife 8:e41641CrossRefPubMedPubMedCentral

Titel: Special Issue: Novel Diagnostic and Therapeutic Approach Options in Lupus Nephritis
Transcriptome Studies in Lupus Nephritis
verfasst von: Marta E. Alarcón-Riquelme
Publikationsdatum: 01.12.2022
Verlag: Springer International Publishing
Erschienen in: Archivum Immunologiae et Therapiae Experimentalis / Ausgabe 1/2022
Print ISSN: 0004-069X
Elektronische ISSN: 1661-4917
DOI: https://doi.org/10.1007/s00005-022-00651-y

Springer Medizin Österreich

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2022

Angiotensin II Type 1 Receptor Antibodies Are Higher in Lupus Nephritis and Vasculitis than Other Glomerulonephritis Patients

Application of Metabolomics in Childhood Leukemia Diagnostics

Recombinant Human Lactoferrin Reduces Inflammation and Increases Fluoroquinolone Penetration to Primary Granulomas During Mycobacterial Infection of C57Bl/6 Mice

Correction to: CD5L Secreted by Macrophage on Atherosclerosis Progression Based on Lipid Metabolism Induced Inflammatory Damage

Study of Plasma Anti-CD26 Autoantibody Levels in a Cohort of Treatment-Naïve Early Arthritis Patients

Elevated Levels of Soluble CD147 are Associated with Hyperinflammation and Disease Severity in COVID-19: A Proof-of-Concept Clinical Study